- 193,"[P] Jaundice or Itching","Jaundice or Itching","Jaundice or Itching","rao@ohdsi.org","Pending peer review","","events of jaundice or itching","#Symptoms",1,"Gowtham A. Rao","'0000-0002-4949-7236'","'OHDSI'","","","137977, 435656","https://forums.ohdsi.org/t/17895","2022-06-29","2023-09-25",,"",,0,,,"ERA","0","fixed duration relative to initial event","EndDate",14,0,"All",FALSE,"All","All",1,1,"ConditionOccurrence",0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,
- 194,"[P] Encephalopathy or its presentations","Encephalopathy or its presentations","Encephalopathy or its presentations","rao@ohdsi.org","Pending peer review","","events Encephalopathy or its presentations","#Symptoms",1,"Gowtham A. Rao","'0000-0002-4949-7236'","'OHDSI'","","","436222","https://forums.ohdsi.org/t/17895","2022-06-29","2023-09-25",,"",,0,,,"ERA","0","fixed duration relative to initial event","EndDate",14,0,"All",FALSE,"All","All",1,1,"ConditionOccurrence",0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,
- 195,"[P] Primary or malignant urothelial bladder cancer","Primary or malignant urothelial bladder cancer","Primary or malignant urothelial bladder cancer","rao@ohdsi.org","Pending peer review","","all events of Primary or malignant urothelial bladder cancer","",1,"Gowtham A. Rao","'0000-0002-4949-7236'","'OHDSI'","","","196360, 197508","","2022-06-30","2023-09-19",,"",,0,,,"ERA","0","fixed duration relative to initial event","EndDate",0,0,"All",FALSE,"All","All",1,1,"ConditionOccurrence",0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,
- 196,"[P] Rheumatoid arthritis or complications","Rheumatoid arthritis or complications","Rheumatoid arthritis or complications","rao@ohdsi.org","Pending peer review","","All events of rheumatoid arthritis or complications","#Disease",1,"Gowtham A. Rao","'0000-0002-4949-7236'","'OHDSI'","","","80809","","2022-06-30","2023-09-19",,"",,0,,,"ERA","0","fixed duration relative to initial event","EndDate",0,0,"All",FALSE,"All","All",2,2,"ConditionOccurrence, Observation",0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,,,,,,,,,,
- 197,"[P] Coronary Artery Disease from vessel disease to ischemic injury","Coronary Artery Disease from vessel disease to ischemic injury","Coronary Artery Disease from vessel disease to ischemic injury","rao@ohdsi.org","Pending peer review","","all occurrence of coronary artery disease","",1,"Gowtham A. Rao","'0000-0002-4949-7236'","'OHDSI'","","","318443, 764123","","2022-06-30","2023-09-19",,"",,0,,,"ERA","0","fixed duration relative to initial event","EndDate",99999,0,"All",FALSE,"All","All",2,2,"ConditionOccurrence, Observation",0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,,,,,,,,,,
- 198,"[P] Crohns disease or its complication","Crohns disease or its complication","Crohns disease or its complication","rao@ohdsi.org","Pending peer review","","All events of crohns disease or complications","#Disease",1,"Gowtham A. Rao","'0000-0002-4949-7236'","'OHDSI'","","","201606","","2022-06-30","2023-09-25",,"",,0,,,"ERA","0","fixed duration relative to initial event","EndDate",365,0,"All",FALSE,"All","All",1,1,"ConditionOccurrence",0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,
- 199,"[P] Major Depressive Disorder","Major Depressive Disorder","Major Depressive Disorder","rao@ohdsi.org","Pending peer review","","All events of major depressive disorder","#Disease",1,"Gowtham A. Rao","'0000-0002-4949-7236'","'OHDSI'","","","440383","","2022-06-30","2023-09-25",,"",,0,,,"ERA","0","fixed duration relative to initial event","EndDate",365,0,"All",FALSE,"All","All",1,1,"ConditionOccurrence",0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,
- 200,"[P] Psoriasis of skin","Psoriasis of skin","Psoriasis of skin","rao@ohdsi.org","Pending peer review","","All events of psoriasis of skin","#Disease",1,"Gowtham A. Rao","'0000-0002-4949-7236'","'OHDSI'","","","140168","","2022-06-30","2023-09-25",,"",,0,,,"ERA","0","fixed duration relative to initial event","EndDate",1095,0,"All",FALSE,"All","All",1,1,"ConditionOccurrence",0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,
- 201,"[P] Ulcerative colitis or complications","Ulcerative colitis or complications","Ulcerative colitis or complications","rao@ohdsi.org","Pending peer review","","All events of Ulcerative colitis or complications","#Disease",1,"Gowtham A. Rao","'0000-0002-4949-7236'","'OHDSI'","","","81893","","2022-06-30","2023-09-25",,"",,0,,,"ERA","0","fixed duration relative to initial event","EndDate",730,0,"All",FALSE,"All","All",1,1,"ConditionOccurrence",0,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,
- 207,"[P] Acquired Pure Red Cell Aplasia","Acquired Pure Red Cell Aplasia","Acquired Pure Red Cell Aplasia","rao@ohdsi.org","Pending peer review","","earliest of acquired pure red cell aplasia indexed on anemia, with no congenital or genetic anemia or constitutional aplasia, and no erroneous measurements such as normal hemoglobin or hematocrit. Persons should not have constitutional aplasia as it represents congenital form of aplasia and should not have bone marrow transplantation","#DME",1,"Azza Shoaibi","'0000-0002-6976-2594'","'OHDSI'","","","26942, 138723, 4144746","https://forums.ohdsi.org/t/17854","2022-11-10","2024-09-11",,"",,0,,,"ERA","0","end of continuous observation",,,6,"All",FALSE,"All","First",4,2,"ConditionOccurrence, Measurement",0,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,,,,,,,,
- 208,"[P] Febrile Neutropenia or Neutropenic Fever","Febrile Neutropenia or Neutropenic Fever","Febrile Neutropenia or Neutropenic Fever","rao@ohdsi.org","Pending peer review","","All events of febrile neutropenia, indexed on the diagnosis of febrile neutropenia or a fever (diagnosis or measurement) cooccurring with neutropenia (diagnosis or measurement) within 1 day , or a diagnosis of clinically significant infection cooccurring with neutropenia (diagnosis or measurement) within 1 day. Restricted to events overlapping with in an inpatient or emergency room visit and excluding events with a normal neutrophil count (ANC) on index.","#DME",1,"'Gowtham A. Rao', 'Azza Shoaibi'","'0000-0002-4949-7236', '0000-0002-6976-2594'","'OHDSI'","","","257011, 437663, 4170143, 4250734","https://forums.ohdsi.org/t/17876","2022-11-10","2023-09-19",,"",,0,,,"ERA","30","fixed duration relative to initial event","EndDate",3,2,"All",TRUE,"All","All",8,3,"ConditionOccurrence, Measurement, Observation",0,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,,,,,,,,,,
- 209,"[P] Hemolytic Anemia Extra corpuscular ex hgpathy, memb defect, g6pd","Hemolytic Anemia Extra corpuscular ex hgpathy, memb defect, g6pd","Hemolytic Anemia Extra corpuscular ex hgpathy, memb defect, g6pd","rao@ohdsi.org","Pending peer review","","all events of hemolytic anemia, indexed on anemia or hemolysis, without congenital or hereditary causes of hemolytic anemia of membrane, enzyme or RBC structure","",1,"Gowtham A. Rao","'0000-0002-4949-7236'","'OHDSI'","","","435503, 439777, 441269, 4250490","https://forums.ohdsi.org/t/17856","2022-11-11","2023-09-19",,"",,0,,,"ERA","0","fixed duration relative to initial event","EndDate",0,9,"All",FALSE,"All","All",5,2,"ConditionOccurrence, Measurement",0,0,12,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,
- 210,"[P] Hemolytic Anemia, without Extra corpuscular ex hgpathy, memb defect","Hemolytic Anemia, without Extra corpuscular ex hgpathy, memb defect","Hemolytic Anemia Extra corpuscular ex hgpathy, memb defect","rao@ohdsi.org","Pending peer review","","all events of hemolytic anemia, indexed on anemia or hemolysis, without congenital or hereditary causes of hemolytic anemia of membrane, or RBC structure. Persons with enzyme disorder (e.g. G-6-PD deficiency) are not excluded","#DME",1,"Gowtham A. Rao","'0000-0002-4949-7236'","'OHDSI'","","","435503, 439777, 441269, 4250490","https://forums.ohdsi.org/t/17856","2022-11-11","2024-10-02",,"",,0,,,"ERA","0","fixed duration relative to initial event","EndDate",0,7,"All",FALSE,"All","All",5,2,"ConditionOccurrence, Measurement",0,0,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,
- 211,"[P] Pancytopenia, Acquired","Pancytopenia, Acquired","Pancytopenia, Acquired","rao@ohdsi.org","Pending peer review","","All events of Pancytopenia, indexed on diagnosis or lab results. Excluded are patients with severe congenital blood disorders that may cause pancytopenia any time prior to 7 days post index. Exist cohort at 60 days post end date. Repeated events will be combined into events eras if they are within 365 days of each other.","#DME",1,"'Gowtham A. Rao', 'Azza Shoaibi'","'0000-0002-4949-7236', '0000-0002-6976-2594'","'OHDSI'","","","432881","","2022-11-11","2024-09-11",,"",,0,,,"ERA","365","fixed duration relative to initial event","EndDate",60,3,"All",FALSE,"All","All",2,2,"ConditionOccurrence, Measurement",0,0,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,
- 213,"[D] Acquired Neutropenia or unspecified leukopenia (21Pe, 365Era)","Acquired Neutropenia or unspecified leukopenia (21Pe, 365Era)","Neutropenia or unspecified leukopenia","rao@ohdsi.org","Accepted","3.11.0","All events of neutropenia indexed on diagnosis or lab results, with no congenital or genetic neutropenia all days pre to 7 days post index. Also excluded, events with normal neutrophil count or a diagnosis of Neutrophilia on index. patients exit 21 days post end date or with the occurrence of a normal neutrophil count. Reoccurring events for the same patients will be combined into event eras if they are within 365 days of each other.","#PhenotypePhebruary, #2023, #Neutropenia, #DME",1,"Gowtham A. Rao","'0000-0002-4949-7236'","'OHDSI'","Anna Ostropolets","","435224","https://forums.ohdsi.org/t/17409","2022-11-11","2024-09-11",,"",,0,,,"ERA","365","fixed duration relative to initial event","EndDate",21,3,"All",FALSE,"All","All",3,2,"ConditionOccurrence, Measurement",0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,
- 214,"[P] Acquired Isolated Neutropenia or unspecified leukopenia","Acquired Isolated Neutropenia or unspecified leukopenia","Acquired Isolated Neutropenia or unspecified leukopenia","rao@ohdsi.org","Pending peer review","","all events of neutropenia indexed on diagnosis or lab results with no congenital or genetic neutropenia, and no other cell lines reduced at the same time","",1,"Gowtham A. Rao","'0000-0002-4949-7236'","'OHDSI'","","","435224","https://forums.ohdsi.org/t/17409","2022-11-11","2023-09-19",,"",,0,,,"ERA","0","fixed duration relative to initial event","EndDate",0,9,"All",FALSE,"All","All",3,2,"ConditionOccurrence, Measurement",0,0,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,
- 215,"[P] Isolated Immune Thrombocytopenia","Isolated Immune Thrombocytopenia","Isolated Immune Thrombocytopenia","rao@ohdsi.org","Pending peer review","","events of Immune Thrombocytopenia (ITP) with no evidence of congenital or genetic thrombocytopenia, and no simultaneous neutropenia, pancytopenia, bone marrow involvement, anemia.","#DME",1,"'Gowtham A. Rao', 'Azza Shoaibi'","'0000-0002-4949-7236', '0000-0002-6976-2594'","'OHDSI'","","","433749, 4103532","","2022-11-11","2023-09-19",,"",,0,,,"ERA","0","fixed duration relative to initial event","EndDate",0,8,"All",FALSE,"All","All",1,1,"ConditionOccurrence",0,0,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,
- 216,"[P] Isolated Immune Thrombocytopenia in absence of common thrombocytopenia causes","Isolated Immune Thrombocytopenia in absence of common thrombocytopenia causes","Isolated Immune Thrombocytopenia in absence of common thrombocytopenia causes","rao@ohdsi.org","Pending peer review","","events of Immune Thrombocytopenia (ITP) with no evidence of congenital or genetic thrombocytopenia, and no simultaneous neutropenia, pancytopenia, bone marrow involvement, anemia. Persons exit after 180 days or when they have normal platelet count. Also no evidence of common causes of thrombocytopenia including hypersplenism, antiphospholipid syndrome, paroxysmal noctural hemoglobinuria, hemolytic uremic syndrome, thrombotic microangiopathy, major autoimmune disorders, chronic liver disease, pregnancy HELLP, tumors of hematopoietic cells or nutritional deficiency","#DME",1,"'Gowtham A. Rao', 'Azza Shoaibi'","'0000-0002-4949-7236', '0000-0002-6976-2594'","'OHDSI'","","","433749, 4103532","","2022-11-11","2024-09-11",,"",,0,,,"ERA","0","fixed duration relative to initial event","EndDate",180,20,"All",FALSE,"All","All",1,1,"ConditionOccurrence",0,0,20,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,,,,,,,
- 217,"[W] Thrombotic microangiopathy (TMA) or Microangiopathic hemolytic anemia (MAHA)","Thrombotic microangiopathy (TMA) or Microangiopathic hemolytic anemia (MAHA)","Thrombotic microangiopathy (TMA) or Microangiopathic hemolytic anemia (MAHA)","rao@ohdsi.org","Pending peer review","","Earliest events of Immune Thrombotic microangiopathy or microangiopathic hemolytic anemia indexed on the diagnosis or its treatment or investigation. Events with congenital or genetic thrombocytopenia all time prior to 7 days post index are excluded. Also excluded are patients with Platelet count > 150. cohort exit is 7 days post end date or an occurrence of a normal platelet measure .","#DME",1,"'Gowtham A. Rao', 'Azza Shoaibi'","'0000-0002-4949-7236', '0000-0002-6976-2594'","'OHDSI'","","","313800, 4119134","","2022-11-11","2023-10-16",,"","same as 741",0,,,"ERA","0","fixed duration relative to initial event","EndDate",7,2,"All",FALSE,"All","First",4,4,"ConditionOccurrence, DrugExposure, Measurement, ProcedureOccurrence",0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,,,1,,1,,,,,
- 218,"[P] Rhabdomyolysis","Rhabdomyolysis","Rhabdomyolysis","rao@ohdsi.org","Pending peer review","","All events of rhabdomyolysis, indexed on a diagnosis or an observation of of Rhabdomyolysis or Myoglobinuria or a diagnosis of Muscle, ligament and fascia disorders co-occurring with a measurement of creatine kinase that is 5 times above the normal range- within 7 days. With no such events in the last 180 days washout period. Restricted to events that overlap with an inpatient visit. Events are excluded if they had recent trauma such as burn, drowning, hypothermia, hyperthermia, hyperpyrexia, crush syndrome, sepsis, march myoglobinuria, exertional rhabdomyolysis or alcohol intoxication, in the last 14 days including index. cohort exit 0 days post end date.","#DME",1,"'Gowtham A. Rao', 'Azza Shoaibi'","'0000-0002-4949-7236', '0000-0002-6976-2594'","'OHDSI'","","","137967, 4345578","","2022-11-11","2024-09-11",,"",,0,,,"ERA","0","fixed duration relative to initial event","EndDate",3,13,"All",FALSE,"All","All",3,2,"ConditionOccurrence, Observation",0,0,14,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,,,,,,,,,,
- 219,"[P] Sudden Cardiac arrest or cardiac death","Sudden Cardiac arrest or cardiac death","Sudden Cardiac arrest or cardiac death","rao@ohdsi.org","Pending peer review","","Earliest event of Sudden Cardiac arrest or Cardiac death, indexed on diagnosis or observation of cardiac arrest or cardiac death or a procedures of resuscitation. Restricting to events overlapping an inpatient or ER visit. Cohort exist is 1 day post cohort end date.","#DME",1,"'Gowtham A. Rao', 'Azza Shoaibi'","'0000-0002-4949-7236', '0000-0002-6976-2594'","'OHDSI'","","","321042","","2022-11-11","2024-09-11",,"",,0,,,"ERA","0","fixed duration relative to initial event","EndDate",1,1,"All",FALSE,"All","First",3,3,"ConditionOccurrence, Observation, ProcedureOccurrence",0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,,,,1,,,,,
This file has been truncated. show original